- Failures in care provided to woman in Timaru Hospital emergency department - Stuff.co.nz
- Anca Vasculitis Drug Market to Witness Explosive Rise by 2027 | ChemoCentryx, GlaxoSmithKline plc, Kineta – Murphy's Hockey Law - Murphy's Hockey Law
- Anca Vasculitis Drug Market 2021 SWOT Analysis, Competitive Landscape and Significant Growth | Top Brands:ChemoCentryx, Inc., GlaxoSmithKline plc, Kineta, Inc…. – Jumbo News - Jumbo News
- Vasculitis Drug Market 2021 SWOT Analysis, Competitive Landscape and Significant Growth | Top Brands:Merck, Sino-US Zibo Xinhua-Perrigo Pharmaceutical, Hainan Pharmaceutical Factory, Bayer, CSPC Ou… – Jumbo News - Jumbo News
- Steroids or intravenous immunoglobulin as first line in MIS-C in LMICs - The Lancet
- Through Infinity and beyond, Adverum gene therapy keeps buzz alive in AMD - BioWorld Online
- Top in rheumatology: Opioids for back pain, MIS-C treatment outcomes - Healio
- Adult-onset Still's disease following COVID-19 vaccination - The Lancet
- Anca Vasculitis Drug Market 2021 SWOT Analysis, Competitive Landscape and Significant Growth | Top Brands:ChemoCentryx, Inc., GlaxoSmithKline plc, Kineta, Inc…. – NeighborWebSJ - NeighborWebSJ
- Global Vasculitis Treatment Market 2021 Growth, Trends, Leading Players and Business Insights Forecast to 2026 - Big News Network
- Roche 1st half boosted by demand for diagnostics - The Pharma Letter
- "Masks aren't a hefty price to pay to save lives" - Stamford Mercury
- Clinical and Histopathological Spectrum of Delayed Adverse Cutaneous Reactions Following COVID-19 Vaccination - Docwire News - DocWire News
- Clinical and Histopathological Spectrum of Delayed Adverse Cutaneous Reactions Following COVID-19 Vaccination - DocWire News
- Arterial Diseases: Risk Factors, Causes, and Symptoms - Verywell Health
Connect with us on social media!
Participate in Research
The Vasculitis Foundation's updated website design was generously funded with a grant by Genentech.
